Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000117

Director sold 63,131 shares at an average $44.43 ($2,805,197)

  • Director gave 300,000 shares (gift)
  • Director gave 300,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Tessier-Lavigne Marc · Director

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-04 Gift : show line 1 in the form −300,000 2,244,370 D
2021-10-04 Gift : show line 2 in the form +100,000 100,000 I
2021-12-28 Sale : show line 3 in the form −3,732 $44.37 $165,589 96,268 I
2021-12-29 Sale : show line 4 in the form −10,700 $43.88 $469,516 85,568 I
2021-12-30 Sale : show line 5 in the form −3,343 $45.13 $150,870 82,225 I
2021-12-30 Sale : show line 6 in the form −3,377 $45.59 $153,957 78,848 I
2021-10-04 Gift : show line 7 in the form +100,000 100,000 I
2021-12-28 Sale : show line 8 in the form −3,602 $44.38 $159,857 96,398 I
Open-market sales · 63,131 sh · avg $44.43 · $2,805,197
Loading xslF345X03/wf-form4_164091956763788.xml…